Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Aberrant Expression of OX1 Receptors for Orexins in Colon Cancers and Liver Metastases: an Openable Gate to Apoptosis
Thierry Voisin, Aadil El Firar, Magali Fasseu, et al.
Cancer Research (2011) Vol. 71, Iss. 9, pp. 3341-3351
Open Access | Times Cited: 87

Showing 26-50 of 87 citing articles:

Orexins promote survival of rat cortical neurons
Paulina Sokołowska, A. Urbańska, Magdalena Namiecińska, et al.
Neuroscience Letters (2011) Vol. 506, Iss. 2, pp. 303-306
Closed Access | Times Cited: 34
Effects of orexin A on glucose metabolism in human hepatocellular carcinoma in vitro via PI3K/Akt/mTOR-dependent and -independent mechanism
Yuanyuan Liu, Yuyan Zhao, Lei Guo
Molecular and Cellular Endocrinology (2015) Vol. 420, pp. 208-216
Closed Access | Times Cited: 32
The orexin receptor OX1R in colon cancer: a promising therapeutic target and a new paradigm in G protein‐coupled receptor signalling through ITIMs
Marc Laburthe, Thierry Voisin
British Journal of Pharmacology (2011) Vol. 165, Iss. 6, pp. 1678-1687
Open Access | Times Cited: 33
Orexin A upregulates the protein expression of OX1R and enhances the proliferation of SGC-7901 gastric cancer cells through the ERK signaling pathway
Yuanyuan Liu, Yuyan Zhao, SHUJING JU, et al.
International Journal of Molecular Medicine (2014) Vol. 35, Iss. 2, pp. 539-545
Open Access | Times Cited: 29
Chronopathophysiological implications of orexin in sleep disturbances and lifestyle-related disorders
Hiroshi Tsuneki, Tsutomu Wada, Toshiyasu Sasaoka
Pharmacology & Therapeutics (2017) Vol. 186, pp. 25-44
Closed Access | Times Cited: 28
Ectopic expression of OX1R in ulcerative colitis mediates anti-inflammatory effect of orexin-A
Nassima Messal, Neïké Fernandez, Stéphanie Dayot, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2018) Vol. 1864, Iss. 11, pp. 3618-3628
Closed Access | Times Cited: 27
Orexin-A protects SH-SY5Y cells against H2O2-induced oxidative damage via the PI3K/MEK1/2/ERK1/2 signaling pathway
Chunmei Wang, Chunqing Yang, Baohua Cheng, et al.
International Journal of Immunopathology and Pharmacology (2018) Vol. 32
Open Access | Times Cited: 26
In vitro, in vivo and ex vivo demonstration of the antitumoral role of hypocretin-1/orexin-A and almorexant in pancreatic ductal adenocarcinoma
Stéphanie Dayot, Daniela Speisky, Anne Couvelard, et al.
Oncotarget (2018) Vol. 9, Iss. 6, pp. 6952-6967
Open Access | Times Cited: 25
Orexin-A Prevents Lipopolysaccharide-Induced Neuroinflammation at the Level of the Intestinal Barrier
Lea Tunisi, Nicola Forte, Alba Clara Fernández-Rilo, et al.
Frontiers in Endocrinology (2019) Vol. 10
Open Access | Times Cited: 24
Orexin A Suppresses the Expression of Exosomal PD-L1 in Colon Cancer and Promotes T Cell Activity by Inhibiting JAK2/STAT3 Signaling Pathway
Jing Wen, Xiaocen Chang, Bowen Bai, et al.
Digestive Diseases and Sciences (2021) Vol. 67, Iss. 6, pp. 2173-2181
Closed Access | Times Cited: 18
Orexins in apoptosis: a dual regulatory role
Simona Cavalu, Sameh Saber, Rabab S. Hamad, et al.
Frontiers in Cellular Neuroscience (2024) Vol. 18
Open Access | Times Cited: 2
Expression and potential role of the peptide orexin-A in prostate cancer
Salvatore Valiante, Giovanna Liguori, Simona Tafuri, et al.
Biochemical and Biophysical Research Communications (2015) Vol. 464, Iss. 4, pp. 1290-1296
Closed Access | Times Cited: 24
Cytotoxic Activity of the Methanolic Extract of Turnera diffusa Willd on Breast Cancer Cells
María del Carmen Avelino-Flores, María del Carmen Cruz-López, Fabiola E. Jiménez-Montejo, et al.
Journal of Medicinal Food (2014) Vol. 18, Iss. 3, pp. 299-305
Open Access | Times Cited: 24
Orexin A affects HepG2 human hepatocellular carcinoma cells glucose metabolism via HIF-1α-dependent and -independent mechanism
Xing Wan, Yuanyuan Liu, Yuyan Zhao, et al.
PLoS ONE (2017) Vol. 12, Iss. 9, pp. e0184213-e0184213
Open Access | Times Cited: 24
Orexin receptor agonist Yan 7874 is a weak agonist of orexin/hypocretin receptors and shows orexin receptor-independent cytotoxicity
Ainoleena Turku, Maiju K. Rinne, Gustav Boije af Gennäs, et al.
PLoS ONE (2017) Vol. 12, Iss. 6, pp. e0178526-e0178526
Open Access | Times Cited: 22
Orexins: A promising target to digestive cancers, inflammation, obesity and metabolism dysfunctions
Alain Couvineau, Thierry Voisin, Pascal Nicole, et al.
World Journal of Gastroenterology (2021) Vol. 27, Iss. 44, pp. 7582-7596
Open Access | Times Cited: 16
The Orexin-A/OX1R System Induces Cell Death in Pancreatic Cancer Cells Resistant to Gemcitabine and Nab-Paclitaxel Treatment
Thierry Voisin, Pascal Nicole, Valérie Gratio, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 11
Crucial role of the orexin‐B C‐terminus in the induction of OX1 receptor‐mediated apoptosis: analysis by alanine scanning, molecular modelling and site‐directed mutagenesis
Pascal Nicole, Pierre Couvineau, Nadège Jamin, et al.
British Journal of Pharmacology (2015) Vol. 172, Iss. 21, pp. 5211-5223
Open Access | Times Cited: 20
Hypothalamic orexin-A (hypocretin-1) neuronal projections to the vestibular complex and cerebellum in the rat
John Ciriello, Monica M. Caverson
Brain Research (2014) Vol. 1579, pp. 20-34
Closed Access | Times Cited: 19
Genes encoding neuropeptide receptors are epigenetic markers in patients with head and neck cancer: a site-specific analysis
Kiyoshi Misawa, Atsushi Imai, Daiki Mochizuki, et al.
Oncotarget (2017) Vol. 8, Iss. 44, pp. 76318-76328
Open Access | Times Cited: 19
Orexins/Hypocretins and Cancer: A Neuropeptide as Emerging Target
Alain Couvineau, Nicole Pascal, Gratio Valérie, et al.
Molecules (2021) Vol. 26, Iss. 16, pp. 4849-4849
Open Access | Times Cited: 15
Recent progress in orexin/hypocretin physiology and pharmacology
Jyrki P. Kukkonen
BioMolecular Concepts (2012) Vol. 3, Iss. 5, pp. 447-463
Open Access | Times Cited: 19
JTC-801 exerts anti-proliferative effects in human osteosarcoma cells by inducing apoptosis
Changjun Zheng, Lili Yang, Jun Liu, et al.
Journal of Receptors and Signal Transduction (2018) Vol. 38, Iss. 2, pp. 133-140
Closed Access | Times Cited: 18
Orexin research: patent news from 2016
Christoph Boss, Catherine Roch
Expert Opinion on Therapeutic Patents (2017) Vol. 27, Iss. 10, pp. 1123-1133
Closed Access | Times Cited: 17
A review of orexin’s unprecedented potential as a novel, highly-specific treatment for various localized and metastatic cancers
Nicole L Graybill, Volkmar Weissig
SAGE Open Medicine (2017) Vol. 5
Open Access | Times Cited: 17

Scroll to top